Slfn14^em1Nvm

CRISPR/Cas9 technology generated a G to T missense mutation resulting in a lysine to asparagine substitution at amino acid 208 (K208N). This mutation is homologous to the K219N mutation observed in patients with thrombocytopenia. (J:325381)